← Back to All Stocks

Rallybio Corporation (RLYB) Analysis

Generated on: 2025-07-31 12:36:51 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 19,686,734 shares

Analysis Values

Current Price
$0.49
Predicted Price
$0.55
Expected Return
10.11%
Confidence Score
0.80
RSI (14)
65.33
MACD
0.04
Volume
311,100
Float Shares
19,686,734
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
250

RLYB

Rallybio Corporation
10.11%
Price: $0.49
Confidence: 0.80
News
Low Float
Last updated: 2025-07-31 12:36:51

Technical Analysis

RSI: 65.33
MACD: 0.04
Technical Analysis Graph

Risk Analysis

Volatility
102.93%
Max Drawdown
-81.06%
Beta
1.0
Risk Score
93.6

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia
Insider Monkey - 2025-07-21 04:14
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best small cap AI stocks to buy according to analysts. On July 8, Rallybio Corporation (NASDAQ:RLYB) announced a definitive agreement to sell its interest in REV102 to its joint venture partner, Recursion Pharmaceuticals. The deal is valued at up to $25 million, with an upfront equity payment […]

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.